Osimertinib Versus Comparator First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors As First-Line Treatment in Patients with Advanced EGFR-mutated Non-Small Cell Lung Cancer: a Chinese, Multicenter, Real-World Cohort StudyDongming Zhang, Xiaoyan Liu,Fangfang Shen,Dahai Zhao,Yuequan Shi,Haoran Zhang, Jia Liu,Xiaoxing Gao,Minjiang Chen,Jing Zhao,Wei Zhong,Junzhen Gao, Min He, Yonggang Liu, Xiaoling Yang,Jianwen Qin,Yuling Tang,Xinlin Mu,Yangchun Gu,Shucai Zhang, Xueqin Chen,Li Pang,Qingwei Meng,Ye Guo,Yuhui Zhang, Wei Li,Puyuan Xing,Yuan Cheng,Tao Xin, Qingxia Li, Yu Li,Jun Chen,Feng Gao,Bo Jin,Antonio Rossi,Hiroyuki Adachi, Francesco Guerrera, Hatim Husain,Yan Xu,Mengzhao WangTranslational Lung Cancer Research（2023）引用 0|浏览5暂无评分关键词EGFR MutationsAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
